Subscribe

Conference Correspondent

Elotuzumab plus Lenalidomide/Dexamethasone in Patients with Relapsed/Refractory MM: ELOQUENT-2 Trial Update
Conference Correspondent, ASH
Conference Correspondent 
In a phase 3 study, researchers assessed the safety and efficacy of elotuzumab plus lenalidomide/dexamethasone, the first immunostimulatory monoclonal antibody for the treatment of relapsed/refractory multiple myeloma. Here, they report 3-year follow-up data. Read More ›
Long-Term Follow-Up of the HOVON-65/GMMG-HD4 Trial of Bortezomib Induction and Maintenance in Patients with Newly Diagnosed MM
Conference Correspondent, ASH
Conference Correspondent 
Researchers report the significant and lasting improvement in progression-free survival and overall survival in patients treated with bortezomib. A subgroup analysis identified bortezomib to have an effect on the high-risk effects of del(17p) and renal impairment on survival. Read More ›
All-Oral Combination of Ixazomib/Cyclophosphamide/Low-Dose Dexamethasone (ICd) in Transplant-Ineligible Newly Diagnosed MM
Conference Correspondent, ASH
Conference Correspondent 
Researchers report the results of a phase 2 study evaluating the tolerability and long-term outcomes using a combination of ixazomib plus cyclophosphamide and low-dose dexamethasone in newly diagnosed multiple myeloma (MM) patients who are not eligible for transplant. Read More ›
Highlights from the 2015 European Cancer Congress
Conference Correspondent
TON November 2015 Vol 8 No 6
The 2015 European Cancer Congress (ECC 2015) was held in Vienna, Austria, from September 25 to 29. The congress was jointly sponsored by the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO). Read More ›
Meeting Update: The International Myeloma Workshop and the Myeloma Nursing Symposium
By Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent
TON November 2015 Vol 8 No 6
The International Myeloma Workshop (IMW) is a biannual meeting in which more than 3000 attendees participate. The workshop focuses on increasing the knowledge of physicians and providers who specialize in the biology and treatment of multiple myeloma (MM), as well as dissemination of new findings and emerging advances in the field. Read More ›
Highlights from the 2015 Annual Meeting of the American Society of Clinical Oncology
Highlights from the 2015 Annual Meeting of the American Society of Clinical Oncology
Conference Correspondent
TON September 2015 Vol 8 No 5
The Annual Meeting of the American Society of Clinical Oncology (ASCO) is the largest and most important oncology specialty meeting in the United States, and arguably the world. More than 30,000 oncology professionals gathered in Chicago, IL, to hear about ground-breaking research, state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. Read More ›
Highlights from the 2015 Annual Congress of the Oncology Nursing Society
Conference Correspondent
TON July 2015 Vol 8 No 4
The 2015 Annual Congress of the Oncology Nursing Society (ONS) marks the 40th anniversary of the organization. Presentations and events included the new and the “tried and true.” Read More ›
Highlights From the 2015 Genitourinary Cancers Symposium
Highlights From the 2015 Genitourinary Cancers Symposium
Conference Correspondent
TON May 2015 Vol 8 No 3
The symposium highlighted 5 of the most important developments affecting nurses and advanced nurse practitioners on the topic of integrating biology into patient-centric care. Read More ›
Highlights From the World Cutaneous Malignancies Congress
Conference Correspondent
TON March 2015 Vol 8 No 2
The Third Annual World Cutaneous Malignancies Congress (WCMC) took place in San Francisco, California, in October 2014. Read More ›
Highlights from ASH and SABCS
By Alice Goodman
Conference Correspondent
TON - January 2015 Vol 8 No 1
The annual meetings of the American Society of Hematology (ASH) and the San Antonio Breast Cancer Symposium (SABCS) took place in December 2014, attracting US and international oncologists interested in the latest research on basic science and clinical medicine. The following articles are a selection of highlights from these meetings. Read More ›

Page 19 of 32


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, monthly TON print publication and TON weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.